{"id":12731,"date":"2026-01-01T19:34:55","date_gmt":"2026-01-01T17:34:55","guid":{"rendered":"https:\/\/stemlix.com\/?p=12731"},"modified":"2026-01-01T19:34:55","modified_gmt":"2026-01-01T17:34:55","slug":"targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment","status":"publish","type":"post","link":"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/","title":{"rendered":"targeting the mitochondrial-stem cell connection in cancer treatment"},"content":{"rendered":"<div class=\"markdown prose dark:prose-invert w-full break-words light markdown-new-styling\"><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">\u0645\u062d\u062a\u0648\u064a\u0627\u062a \u0627\u0644\u0635\u0641\u062d\u0629<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#Targeting_the_Mitochondrial-Stem_Cell_Connection_in_Cancer_Treatment\" >Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#Understanding_Cancer_Stem_Cells_CSCs\" >Understanding Cancer Stem Cells (CSCs)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#The_Role_of_Mitochondria_in_Cancer_Stem_Cells\" >The Role of Mitochondria in Cancer Stem Cells<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#Mitochondrial_Dysfunction_and_Cancer_Progression\" >Mitochondrial Dysfunction and Cancer Progression<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#Targeting_the_Mitochondrial-Stem_Cell_Connection_in_Cancer_Treatment-2\" >Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#1_Mitochondrial-Targeted_Therapies\" >1. Mitochondrial-Targeted Therapies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#2_Modulating_Mitochondrial_Dynamics\" >2. Modulating Mitochondrial Dynamics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#3_Gene_Editing_Approaches\" >3. Gene Editing Approaches<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#4_Targeting_Mitochondrial_Biogenesis\" >4. Targeting Mitochondrial Biogenesis<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#Combining_Mitochondrial_Targeting_with_Traditional_Therapies\" >Combining Mitochondrial Targeting with Traditional Therapies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#Challenges_and_Future_Directions\" >Challenges and Future Directions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/stemlix.com\/en\/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n<h3 data-start=\"0\" data-end=\"72\"><span class=\"ez-toc-section\" id=\"Targeting_the_Mitochondrial-Stem_Cell_Connection_in_Cancer_Treatment\"><\/span>Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"74\" data-end=\"683\">The complex relationship between mitochondria and stem cells is gaining significant attention in cancer treatment research. Stem cells, with their regenerative potential and ability to self-renew, play a central role in the development and progression of cancers. Meanwhile, mitochondria, the powerhouse of the cell, are vital for energy production, cellular metabolism, and maintaining the cell&#8217;s overall health. Recent findings suggest that mitochondrial dysfunction and altered mitochondrial dynamics are linked to cancer stem cell (CSC) survival, proliferation, and resistance to conventional treatments.<\/p>\n<p data-start=\"685\" data-end=\"891\">In this article, we will explore how the mitochondrial-stem cell connection is being targeted in cancer treatment strategies and the potential benefits this approach may offer in improving patient outcomes.<\/p>\n<h3 data-start=\"893\" data-end=\"935\"><span class=\"ez-toc-section\" id=\"Understanding_Cancer_Stem_Cells_CSCs\"><\/span>Understanding Cancer Stem Cells (CSCs)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"937\" data-end=\"1331\">Cancer stem cells are a subset of tumor cells that possess stem cell-like properties, including self-renewal and differentiation potential. These cells are thought to be responsible for tumor initiation, progression, metastasis, and relapse after treatment. CSCs are more resistant to conventional therapies such as chemotherapy and radiation, making them a major challenge in cancer treatment.<\/p>\n<h3 data-start=\"1333\" data-end=\"1382\"><span class=\"ez-toc-section\" id=\"The_Role_of_Mitochondria_in_Cancer_Stem_Cells\"><\/span>The Role of Mitochondria in Cancer Stem Cells<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"1384\" data-end=\"1670\">Mitochondria are essential in regulating cellular energy metabolism, apoptosis (programmed cell death), and redox balance, which is crucial for maintaining cellular homeostasis. In CSCs, mitochondria are often altered to support the unique metabolic needs of these cells, which include:<\/p>\n<ul data-start=\"1672\" data-end=\"2093\">\n<li data-start=\"1672\" data-end=\"1788\">\n<p data-start=\"1674\" data-end=\"1788\"><strong data-start=\"1674\" data-end=\"1698\">Increased glycolysis<\/strong>: This allows CSCs to thrive in low-oxygen environments, a common feature in solid tumors.<\/p>\n<\/li>\n<li data-start=\"1789\" data-end=\"1941\">\n<p data-start=\"1791\" data-end=\"1941\"><strong data-start=\"1791\" data-end=\"1838\">Enhanced oxidative phosphorylation (OXPHOS)<\/strong>: Many CSCs rely on OXPHOS for energy production, which increases their resistance to oxidative stress.<\/p>\n<\/li>\n<li data-start=\"1942\" data-end=\"2093\">\n<p data-start=\"1944\" data-end=\"2093\"><strong data-start=\"1944\" data-end=\"1972\">Mitochondrial biogenesis<\/strong>: Increased mitochondrial production ensures that CSCs have sufficient energy to support their self-renewal and survival.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"2095\" data-end=\"2234\">These metabolic alterations provide CSCs with a survival advantage, helping them evade therapies designed to target rapidly dividing cells.<\/p>\n<h3 data-start=\"2236\" data-end=\"2288\"><span class=\"ez-toc-section\" id=\"Mitochondrial_Dysfunction_and_Cancer_Progression\"><\/span>Mitochondrial Dysfunction and Cancer Progression<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"2290\" data-end=\"2485\">Mitochondrial dysfunction is often observed in cancer cells, and it plays a crucial role in the development and progression of tumors. In CSCs, this dysfunction is linked to several key features:<\/p>\n<ul data-start=\"2487\" data-end=\"3012\">\n<li data-start=\"2487\" data-end=\"2676\">\n<p data-start=\"2489\" data-end=\"2676\"><strong data-start=\"2489\" data-end=\"2516\">Resistance to apoptosis<\/strong>: Dysfunctional mitochondria fail to trigger cell death pathways, allowing CSCs to survive even when exposed to treatments that would normally induce apoptosis.<\/p>\n<\/li>\n<li data-start=\"2677\" data-end=\"2858\">\n<p data-start=\"2679\" data-end=\"2858\"><strong data-start=\"2679\" data-end=\"2712\">Increased genomic instability<\/strong>: Damaged mitochondria contribute to a high rate of mutation, which can lead to the accumulation of genetic changes that drive cancer progression.<\/p>\n<\/li>\n<li data-start=\"2859\" data-end=\"3012\">\n<p data-start=\"2861\" data-end=\"3012\"><strong data-start=\"2861\" data-end=\"2879\">Immune evasion<\/strong>: Mitochondrial alterations in CSCs can also affect their interaction with the immune system, helping them avoid immune surveillance.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"3014\" data-end=\"3161\">Targeting mitochondrial dysfunction in CSCs could, therefore, help overcome the resistance of these cells to treatment and reduce tumor recurrence.<\/p>\n<h3 data-start=\"3163\" data-end=\"3235\"><span class=\"ez-toc-section\" id=\"Targeting_the_Mitochondrial-Stem_Cell_Connection_in_Cancer_Treatment-2\"><\/span>Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"3237\" data-end=\"3523\">Recent research has focused on strategies to target the mitochondrial-stem cell connection in cancer therapies. These approaches aim to disrupt mitochondrial function in CSCs, potentially leading to their death or sensitizing them to other treatments. Some promising strategies include:<\/p>\n<h4 data-start=\"3525\" data-end=\"3569\"><span class=\"ez-toc-section\" id=\"1_Mitochondrial-Targeted_Therapies\"><\/span>1. <strong data-start=\"3533\" data-end=\"3569\">Mitochondrial-Targeted Therapies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"3570\" data-end=\"3760\">Several compounds are being developed that specifically target mitochondrial function in CSCs. These therapies aim to exploit the unique features of mitochondrial metabolism in cancer cells:<\/p>\n<ul data-start=\"3762\" data-end=\"4165\">\n<li data-start=\"3762\" data-end=\"4006\">\n<p data-start=\"3764\" data-end=\"4006\"><strong data-start=\"3764\" data-end=\"3792\">Mitochondrial inhibitors<\/strong>: These drugs block mitochondrial respiration, depriving CSCs of energy. Examples include metformin, a well-known drug used in diabetes, which has shown potential in inhibiting mitochondrial OXPHOS in cancer cells.<\/p>\n<\/li>\n<li data-start=\"4007\" data-end=\"4165\">\n<p data-start=\"4009\" data-end=\"4165\"><strong data-start=\"4009\" data-end=\"4048\">Mitochondrial-targeted antioxidants<\/strong>: These agents reduce oxidative stress in CSCs, which may help restore mitochondrial function and promote CSC death.<\/p>\n<\/li>\n<\/ul>\n<h4 data-start=\"4167\" data-end=\"4212\"><span class=\"ez-toc-section\" id=\"2_Modulating_Mitochondrial_Dynamics\"><\/span>2. <strong data-start=\"4175\" data-end=\"4212\">Modulating Mitochondrial Dynamics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"4213\" data-end=\"4539\">Mitochondria are dynamic organelles that constantly undergo fusion and fission, processes that help maintain mitochondrial function and integrity. In CSCs, altered mitochondrial dynamics contribute to their survival. Targeting these processes with drugs that regulate mitochondrial fusion or fission could impair CSC function.<\/p>\n<h4 data-start=\"4541\" data-end=\"4576\"><span class=\"ez-toc-section\" id=\"3_Gene_Editing_Approaches\"><\/span>3. <strong data-start=\"4549\" data-end=\"4576\">Gene Editing Approaches<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"4577\" data-end=\"4836\">Gene editing technologies, such as CRISPR\/Cas9, allow for precise alterations in the mitochondrial genome. This could be used to disrupt the mitochondrial DNA in CSCs, impairing their ability to generate energy and increasing their vulnerability to therapies.<\/p>\n<h4 data-start=\"4838\" data-end=\"4884\"><span class=\"ez-toc-section\" id=\"4_Targeting_Mitochondrial_Biogenesis\"><\/span>4. <strong data-start=\"4846\" data-end=\"4884\">Targeting Mitochondrial Biogenesis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"4885\" data-end=\"5170\">Mitochondrial biogenesis is the process by which cells produce new mitochondria. In CSCs, this process is often upregulated to meet their energy demands. Drugs that inhibit mitochondrial biogenesis could prevent CSCs from maintaining their metabolic advantages, leading to their death.<\/p>\n<h3 data-start=\"5172\" data-end=\"5236\"><span class=\"ez-toc-section\" id=\"Combining_Mitochondrial_Targeting_with_Traditional_Therapies\"><\/span>Combining Mitochondrial Targeting with Traditional Therapies<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"5238\" data-end=\"5677\">Targeting mitochondrial function in CSCs may also enhance the effectiveness of traditional cancer treatments. By combining mitochondrial-targeting drugs with chemotherapy, immunotherapy, or radiation therapy, it may be possible to overcome CSC resistance and achieve better treatment outcomes. These combination therapies could sensitize CSCs to other treatment modalities, leading to improved tumor control and reduced risk of recurrence.<\/p>\n<h3 data-start=\"5679\" data-end=\"5715\"><span class=\"ez-toc-section\" id=\"Challenges_and_Future_Directions\"><\/span>Challenges and Future Directions<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"5717\" data-end=\"5839\">While targeting the mitochondrial-stem cell connection holds great promise in cancer treatment, several challenges remain:<\/p>\n<ul data-start=\"5841\" data-end=\"6334\">\n<li data-start=\"5841\" data-end=\"6012\">\n<p data-start=\"5843\" data-end=\"6012\"><strong data-start=\"5843\" data-end=\"5866\">Tumor heterogeneity<\/strong>: Tumors are composed of a diverse mix of cancer cells, and CSCs may evolve over time, making it difficult to develop one-size-fits-all therapies.<\/p>\n<\/li>\n<li data-start=\"6013\" data-end=\"6204\">\n<p data-start=\"6015\" data-end=\"6204\"><strong data-start=\"6015\" data-end=\"6037\">Off-target effects<\/strong>: Mitochondrial-targeting drugs could have unintended side effects on healthy cells, particularly in tissues with high energy demands, such as muscle and brain tissue.<\/p>\n<\/li>\n<li data-start=\"6205\" data-end=\"6334\">\n<p data-start=\"6207\" data-end=\"6334\"><strong data-start=\"6207\" data-end=\"6232\">Resistance mechanisms<\/strong>: CSCs are highly adaptable and may develop resistance to mitochondrial-targeting therapies over time.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"6336\" data-end=\"6517\">Despite these challenges, ongoing research into the mitochondrial-stem cell connection is providing valuable insights into new strategies for overcoming cancer treatment resistance.<\/p>\n<h3 data-start=\"6519\" data-end=\"6527\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"6529\" data-end=\"6786\"><strong data-start=\"6529\" data-end=\"6570\">1. What are cancer stem cells (CSCs)?<\/strong><br>\nCancer stem cells are a small population of tumor cells with the ability to self-renew and differentiate. They are thought to contribute to cancer initiation, progression, metastasis, and recurrence after treatment.<\/p>\n<p data-start=\"6788\" data-end=\"7020\"><strong data-start=\"6788\" data-end=\"6840\">2. How do mitochondria affect cancer stem cells?<\/strong><br>\nMitochondria play a critical role in the metabolism and survival of CSCs. Altered mitochondrial function supports CSC self-renewal, resistance to treatment, and tumor progression.<\/p>\n<p data-start=\"7022\" data-end=\"7296\"><strong data-start=\"7022\" data-end=\"7104\">3. Can mitochondrial-targeting therapies be used to treat all types of cancer?<\/strong><br>\nMitochondrial-targeting therapies show promise in various cancers, but their effectiveness may vary depending on the tumor type, stage, and the specific metabolic characteristics of the CSCs.<\/p>\n<p data-start=\"7298\" data-end=\"7539\"><strong data-start=\"7298\" data-end=\"7370\">4. What are the risks of targeting mitochondria in cancer treatment?<\/strong><br>\nMitochondrial-targeting therapies may have side effects on normal cells with high energy needs. Additionally, CSCs may develop resistance to these treatments over time.<\/p>\n<p data-start=\"7541\" data-end=\"7776\"><strong data-start=\"7541\" data-end=\"7604\">5. How does mitochondrial dysfunction contribute to cancer?<\/strong><br>\nMitochondrial dysfunction can lead to resistance to apoptosis, increased mutation rates, and immune evasion, all of which contribute to cancer development and progression.<\/p>\n<p data-start=\"7778\" data-end=\"8050\" data-is-last-node=\"\" data-is-only-node=\"\">By understanding and manipulating the mitochondrial-stem cell connection, researchers are developing new cancer treatments that could more effectively target the root cause of tumor growth, offering hope for better outcomes in patients with resistant or recurrent cancers.<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment The complex relationship between mitochondria and stem cells is gaining significant attention in cancer treatment research. Stem cells, with their regenerative potential and ability to self-renew, play a central role in the development and progression of cancers. Meanwhile, mitochondria, the powerhouse of the cell, are vital for&#8230;<\/p>","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-12731","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts\/12731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/comments?post=12731"}],"version-history":[{"count":1,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts\/12731\/revisions"}],"predecessor-version":[{"id":12972,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts\/12731\/revisions\/12972"}],"wp:attachment":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/media?parent=12731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/categories?post=12731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/tags?post=12731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}